Loading…

A one-pot multicomponent facile synthesis of dihydropyrimidin-2(1)-thione derivatives using triphenylgermane as a catalyst and its binding pattern validation

A series of substituted dihydropyrimidin-2(1 H )-thione derivatives ( 1-8 ) have been synthesized using a facile and modified procedure with triphenylgermyl propionate as a catalyst. In comparison with the classical Biginelli reaction, this new protocol has the advantages of excellent yield and shor...

Full description

Saved in:
Bibliographic Details
Published in:RSC advances 2016-01, Vol.6 (83), p.79651-79661
Main Authors: Andleeb, Sohaila, Imtiaz-ud-Din, Rauf, Muhammad Khawar, Azam, Syed Sikander, Badshah, Amin, Sadaf, Haseeba, Raheel, Ahmed, Tahir, Muhammad Nawaz, Raza, Saad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of substituted dihydropyrimidin-2(1 H )-thione derivatives ( 1-8 ) have been synthesized using a facile and modified procedure with triphenylgermyl propionate as a catalyst. In comparison with the classical Biginelli reaction, this new protocol has the advantages of excellent yield and shorter reaction times. The synthesized compounds have been characterized by various spectroscopic techniques such as FT-IR, multinuclear ( 1 H/ 13 C) NMR spectroscopy and single crystal XRD analysis. Molecular docking studies were performed to identify the probable binding modes of potent inhibitors in the active site of the enzymes human topoisomerase II alpha ( 4FM9 ) and Helicobacter pylori urease ( 1E9Y ). Compound 3 was found to be the most potent inhibitor according to the molecular docking scores and molecular dynamic simulations which suggests it can be further processed as a lead molecule to interpret the pharmacological properties of these compounds. A series of substituted dihydropyrimidin-2(1 H )-thione derivatives ( 1-8 ) have been synthesized and docked against enzymes human topoisomerase II alpha ( 4FM9 ) and Helicobacter pylori urease ( 1E9Y ) for binding mode validation.
ISSN:2046-2069
2046-2069
DOI:10.1039/c6ra19162b